US Patent Issued to Dana-Farber Cancer Institute on Aug. 18 for "Potent and selective irreversible inhibitors of IRAK1" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,607, issued on Aug. 18, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Potent and selective irreversible inhibitors of IRAK1" was invented by John M. Hatcher (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compounds that act as irreversible inhibitors interleukin 1 (IL-1) receptor-associated kinases (IRAKs); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases."

The patent was filed on March 22, 2021, under Application No. 17/906,938.

*For further information, including images, charts an...